Company
Kivu Bioscience
Accelerating development of kinder and gentler next-generation ADCs
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Mateo, CA, United States
Claim, correct or request removal
Record updated 28 September 2026
About
a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) for difficult-to-treat cancers
Products
- Web
- KIVU-107
- Web
- KIVU-202
- Web
- KIVU-305
- Web
- KIVU-495
Loading relationship preview